April 14, 2023
1 min read

SoftBank offloads its VC arm

The acquisition comes after SoftBank and its Vision Fund registered huge financial losses amid the overall slump in the world of technology…reports Asian Lite News

Japanese investment giant SoftBank is selling one of its venture capital arms, SoftBank Ventures Asia (SBVA), to Singaporean investment firm The Edgeof, as VC funding remains scarce amid the global macroeconomic conditions.

The acquisition comes after SoftBank and its Vision Fund registered huge financial losses amid the overall slump in the world of technology.

The Edgeof, a newly-established entity, will be led by Founder Taizo Son (SoftBank CEO Masayoshi Son’s younger brother), and Co-founder and Chairman Atsushi Taira from the founding team of Mistletoe.

The Edgeof will leverage Mistletoe’s know-how and establish a pan-Asian ecosystem for ‘aStartups’ by discovering, investing and supporting the growth of game-changing startups, the companies said in a statement.

The company defines “aStartups” as startups that have a mission to address fundamental problems in the world with advanced technology.

SoftBank Group will collaborate closely with The Edgeof, offering valuable expertise, industry insights, and an extensive network to drive innovation and promote growth.

The acquisition is contingent upon regulatory approval and is expected to be completed this year.

“Through this acquisition, we aspire to build an ecosystem that enables visionary entrepreneurs and their startups to effect significant, positive societal change,” said Taira.

Following the acquisition, a fresh brand identity will be unveiled to signify the firm’s commitment to cultivating groundbreaking technologies across the region.

Son, Founder, The Edgeof, said, “We are confident that our collective strengths and resources will ignite a new era of revolutionary technologies and solutions, establishing us as a prominent influence in developing and expanding startups worldwide.”

Founded in 2000, SoftBank Ventures Asia is an early-stage venture capital firm based in Seoul and currently operates nearly $2 billion funds under management.

Since its inception, SoftBank Ventures Asia has focused on ICT investments, including AI, IoT, and smart robotics, with global investment professionals in Seoul, Beijing, Singapore, and San Francisco.

In February this year, SoftBank had posted a loss of nearly $6 billion in the quarter that ended in December.

ALSO READ: EY U-turns on ‘Project Everest’

Previous Story

Intel, ARM strike ‘chip’ deal

Next Story

Chinese spies find news routes to slipping into UK

Previous Story

Intel, ARM strike ‘chip’ deal

Next Story

Chinese spies find news routes to slipping into UK

Latest from Business

Ambani’s Jio launches $3.2bn share sale in India

Jio Platforms, the digital and telecommunications business controlled by Mukesh Ambani’s Reliance Industries, has launched a $3.2 billion initial public offering, expected to become India’s largest share sale. The offering comes amid

Cyber Chiefs Urge Urgent PHP Security Update

Cybersecurity agencies in the UK, EU and Australia have warned organisations to install critical PHP security fixes immediately or consider taking vulnerable websites offline amid reports of emerging attacks, reports Asianlite News

UK firms land £330m Africa deals

British exporters are set to benefit from more than £330 million in contracts for schools, water, electricity and government infrastructure projects in Guinea and Benin…reports Africa Daily News Desk British businesses are

US Bans DeepSeek from Government Systems

Washington has barred Chinese AI technology from civilian government agencies, citing wider concerns over security and competition as the US seeks to maintain its lead in artificial intelligence, reports Asianlite News Desk.
Go toTop

Don't Miss

Indian Crew on Singapore Ship Safe After Baltimore Crash

The ship was bound from Baltimore to Colombo….reports Asian Lite

India, Paraguay review their bilateral ties

Paraguay thanked India for timely supplying Made in India Covaxin